Smoking Treatment of Prisoners

Smoking Treatment of Prisoners: Project STOP

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00110630

Acronym

STOP

Enrollment

250

Registered

2005-05-11

Start date

2005-06-30

Completion date

2007-09-30

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Cessation, Tobacco Use Disorder

Keywords

nicotine dependence

Brief summary

The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.

Detailed description

This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.

Interventions

BEHAVIORAL10-week smoking cessation group therapy combined with NicoDerm CQ

Study design

Allocation

RANDOMIZED

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

* 1\) current smoker and (2) seeking group treatment to quit smoking.

Exclusion criteria

* (1) non-english speaking, (2) housed in segregation, (3) presence of active, severe mental illness as defined by active psychosis, manic episode, or imminently suicidal/homicidal, (4) mental retardation such that they cannot provide informed consent, and (5) due to be released or transferred to another facility within the next year.

Design outcomes

Primary

Measure	Time frame
smoking cessation	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026